These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3460521)

  • 21. Antibiotic susceptibility and genomic variations in Staphylococcus aureus associated with Skin and Soft Tissue Infection (SSTI) disease groups.
    Changchien CH; Chen SW; Chen YY; Chu C
    BMC Infect Dis; 2016 Jun; 16():276. PubMed ID: 27287530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterisation of antibiotic resistance, virulence, clonality and mortality in MRSA and MSSA bloodstream infections at a tertiary-level hospital in Hungary: a 6-year retrospective study.
    Horváth A; Dobay O; Sahin-Tóth J; Juhász E; Pongrácz J; Iván M; Fazakas E; Kristóf K
    Ann Clin Microbiol Antimicrob; 2020 May; 19(1):17. PubMed ID: 32381015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of imipenem-cilastatin therapy on fecal flora.
    Welkon CJ; Long SS; Gilligan PH
    Antimicrob Agents Chemother; 1986 May; 29(5):741-3. PubMed ID: 3460522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Investigation of macrolide, lincosamide and streptogramin B resistance in Staphylococcus aureus strains isolated from clinical samples by phenotypical and genotypical methods].
    Aydeniz Ozansoy F; Cevahir N; Kaleli İ
    Mikrobiyol Bul; 2015 Jan; 49(1):1-14. PubMed ID: 25706726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial resistance and virulence markers in methicillin sensitive Staphylococcus aureus isolates associated with nasal colonization.
    Sarkar A; Raji A; Garaween G; Soge O; Rey-Ladino J; Al-Kattan W; Shibl A; Senok A
    Microb Pathog; 2016 Apr; 93():8-12. PubMed ID: 26796298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative clinical evaluation of imipenem/cilastatin vs. cefotaxime in treatment of severe bacterial infections.
    Stamboulian D; Argüello EA; Jasovich A; Villar O; Maglio F
    Rev Infect Dis; 1985; 7 Suppl 3():S458-62. PubMed ID: 3901208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of staphylococcal cassette chromosome mec-associated DNA segments in multiresistant methicillin-susceptible Staphylococcus aureus (MSSA) and identification of Staphylococcus epidermidis ccrAB4 in both methicillin-resistant S. aureus and MSSA.
    Shore AC; Rossney AS; O'Connell B; Herra CM; Sullivan DJ; Humphreys H; Coleman DC
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4407-19. PubMed ID: 18852274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic efficacy of BO-3482, a novel dithiocarbamate carbapenem, in mice infected with methicillin-resistant Staphylococcus aureus.
    Nagano R; Shibata K; Naito T; Fuse A; Asano K; Hashizume T; Nakagawa S
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2278-81. PubMed ID: 9333062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imipenem/cilastatin therapy for serious infections in neonates and infants.
    Nalin DR; Jacobsen CA
    Scand J Infect Dis Suppl; 1987; 52():46-55. PubMed ID: 3331042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Next-Generation Sequence Analysis Reveals Transfer of Methicillin Resistance to a Methicillin-Susceptible Staphylococcus aureus Strain That Subsequently Caused a Methicillin-Resistant Staphylococcus aureus Outbreak: a Descriptive Study.
    Weterings V; Bosch T; Witteveen S; Landman F; Schouls L; Kluytmans J
    J Clin Microbiol; 2017 Sep; 55(9):2808-2816. PubMed ID: 28679522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial.
    Calandra GB; Hesney M; Brown KR
    Clin Ther; 1985; 7(2):225-38. PubMed ID: 3886144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imipenem/cilastatin in the treatment of severe hospital infections.
    Patoia L; Menichetti F; Bucaneve G; Pasticci MB; Baratta E; Grignani F; Del Favero A
    Chemioterapia; 1988 Apr; 7(2):105-8. PubMed ID: 3165056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibacterial activity of imipenem: the first thienamycin antibiotic.
    Kropp H; Gerckens L; Sundelof JG; Kahan FM
    Rev Infect Dis; 1985; 7 Suppl 3():S389-410. PubMed ID: 3931196
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Mohammadi-Berenjestanaki H; Khori V; Shirzad-Aski H; Ghaemi EA
    Microb Drug Resist; 2020 Mar; 26(3):218-226. PubMed ID: 31424323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Excellent activity of FK037, a novel parenteral broad-spectrum cephalosporin, against methicillin-resistant staphylococci.
    Mine Y; Watanabe Y; Sakamoto H; Hatano K; Kuno K; Kamimura T; Tawara S; Matsumoto Y; Matsumoto F; Kuwahara S
    J Antibiot (Tokyo); 1993 Jan; 46(1):99-119. PubMed ID: 8436564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children.
    Martínez-Aguilar G; Hammerman WA; Mason EO; Kaplan SL
    Pediatr Infect Dis J; 2003 Jul; 22(7):593-8. PubMed ID: 12867833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imipenem/cilastatin for the treatment of infections in hospitalized children.
    Alpert G; Dagan R; Connor E; Campos JM; Bloh AM; Powell KR; Plotkin SA
    Am J Dis Child; 1985 Nov; 139(11):1153-6. PubMed ID: 3904406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of methicillin resistant Staphylococcus aureus in Karnataka.
    Hanumanthappa AR; Chandrappa NR; Rajasekharappa MG
    Indian J Pathol Microbiol; 2003 Jan; 46(1):129-32. PubMed ID: 15027755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical effect of the combined therapy of arbekacin and imipenem/cilastatin against methicillin-resistant Staphylococcus aureus].
    Hashimoto A; Ohtsubo T; Tomono K; Kaku M; Koga H; Kohno S; Hara K; Sugiyama H; Taira K; Inoue Y
    Jpn J Antibiot; 1994 Jun; 47(6):804-12. PubMed ID: 8072190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of staphylococcal pyelonephritis in rats with N-formimidoyl thienamycin.
    Guze PA; Kalmanson GM; Ishida K; Freedman LR; Guze LB
    Chemioterapia; 1984 Feb; 3(1):53-6. PubMed ID: 6598578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.